Goldman Sachs Cuts Myriad Genetics To Sell, Ups Alere By: Benzinga via Benzinga March 26, 2015 at 15:33 PM EDT Myriad Genetics, Inc. (NASDAQ: MYGN) will face mounting evidence in the first-quarter earnings season of dwindling market share and ... Read More >> Related Stocks: Exact Sciences Cor Hologic Inc Myriad Genetics Inc T2 Biosystems CS